Seasonal Influenza Vaccines - Current and Future Players - Product Image

Seasonal Influenza Vaccines - Current and Future Players

  • ID: 4043193
  • Report
  • 99 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • AstraZeneca (MedImmune)
  • CSL Limited (Seqirus)
  • Daiichi Sankyo
  • GlaxoSmithKline
  • Mitsubishi Tanabe Pharma
  • Mylan
  • MORE
Seasonal Influenza Vaccines - Current and Future Players

Summary

The report “Seasonal Influenza Vaccines - Current and Future Players” is a vital source of up-to-date information with in-depth analysis on the companies in the rapidly growing Seasonal Influenza Vaccines Market. The report identifies and analyses the key companies shaping and driving the global Seasonal Influenza Vaccines market. The report provides insight into the competitive Seasonal Influenza Vaccines landscape, including new companies entering the market. This report is built using data and information sourced from proprietary databases, primary and secondary and in-house analysis by a team of industry experts.

Scope

- Investigation of current and future market competition for Seasonal Influenza Vaccines
- Competitor assessment
- Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
- Strategic assessment of Seasonal Influenza Vaccines sector through market impact analysis, future market scenario and company analysis

Reasons to buy

- Gain a high level view of the trends shaping and driving Seasonal Influenza Vaccines market
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market
- What’s the next big thing in the global Seasonal Influenza Vaccines market landscape? Identify, understand and capitalize
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • AstraZeneca (MedImmune)
  • CSL Limited (Seqirus)
  • Daiichi Sankyo
  • GlaxoSmithKline
  • Mitsubishi Tanabe Pharma
  • Mylan
  • MORE
1. List of Tables and Figures

2 Introduction

2.1 Catalyst

2.2 Related Reports

2.3 Upcoming Related Reports

3 Market Outlook

3.1 Global Markets

3.1.1 Forecast

3.1.2 Drivers and Barriers - Global Issues

4 Current and Future Players

4.1 Overview

4.2 Trends in Corporate Strategy

4.3 Company Profiles - Major Players

4.3.1 Sanofi

4.3.2 CSL Limited (Seqirus)

4.3.3 GlaxoSmithKline

4.3.4 AstraZeneca (MedImmune)

4.3.5 Protein Sciences Corporation

4.3.6 Mitsubishi Tanabe Pharma

4.3.7 Novavax

4.4 Other Companies

4.4.1 Mylan

4.4.2 Daiichi Sankyo

5 Appendix

5.1 Bibliography

5.2 Abbreviations

5.3 Methodology

5.4 Forecasting Methodology

5.4.1 Vaccine Coverage

5.4.2 Vaccines Included

5.4.3 Key Launch Dates

5.4.4 Influenza Vaccine Tender System Assumptions

5.4.5 General Pricing Assumptions

5.4.6 Individual Vaccine Assumptions

5.4.7 Pricing of Pipeline Agents

5.5 Primary Research - KOLs Interviewed for this Report

5.6 Primary Research - Prescriber Survey

5.7 About the Authors

5.7.1 Analyst

5.7.2 Therapy Area Director

5.7.3 Epidemiologists

5.7.4 Director of Epidemiology

5.7.5 Global Director of Therapy Analysis and Epidemiology

5.8 About

5.9 Disclaimer

List of Tables

Table 1: Global (7MM) Sales Forecasts ($m) for Seasonal Influenza Vaccines, 2015-2025

Table 2: Seasonal Influenza Vaccines Market - Drivers and Barriers, 7MM, 2015-2025

Table 3: Key Companies in the Seasonal Influenza Vaccines Market, 2016

Table 4: Sanofi’s Seasonal Influenza Vaccine Portfolio Assessment, 2016

Table 5: CSL Limited’s Seasonal Influenza Vaccine Portfolio Assessment, 2016

Table 6: GSK’s Seasonal Influenza Vaccine Portfolio Assessment, 2016

Table 7: AstraZeneca’s Seasonal Influenza Vaccine Portfolio Assessment, 2016

Table 8: Protein Sciences Corporation’s Seasonal Influenza Vaccine Portfolio Assessment, 2016

Table 9: Mitsubishi’s Seasonal Influenza Vaccine Portfolio Assessment, 2016

Table 10: Novavax’s Seasonal Influenza Vaccine Portfolio Assessment, 2016

Table 11: Key Launch Dates

Table 12: High-Prescribing Physicians (non-KOLs) Surveyed, By Country

List of Figures

Figure 1: Global (7MM) Sales for Seasonal Influenza Vaccines by Country, 2015 and 2025

Figure 2: Company Portfolio Gap Analysis in Seasonal Influenza Vaccines, 2015-2025
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Sanofi
  • CSL Limited (Seqirus)
  • GlaxoSmithKline
  • AstraZeneca (MedImmune)
  • Protein Sciences Corporation
  • Mitsubishi Tanabe Pharma
  • Novavax
  • Mylan
  • Daiichi Sankyo
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll